drugset / Trial / NCT00676130
Study of New Antibiotic Regimen for the Treatment of Uncomplicated Cellulitis in Emergency Department Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
The primary aim of this study is to quantify the effectiveness of Bactrim as additional therapy for the treatment of uncomplicated cellulitis in adults, by comparing: standard therapy plus Bactrim, versus standard therapy plus placebo. The primary hypothesis of this study is that, in light of increasing CA-MRSA prevalence, subjects treated with standard therapy plus Bactrim will have higher cure rates than those treated with standard therapy plus placebo.
Timeline
- Start
- 2007-05
- Primary completion
- 2012-05
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | trimethoprim-sulfamethoxazole | Unknown | 40 mg | — |
| Subject | trimethoprim-sulfamethoxazole | Unknown | 60 mg | — |
| Subject | trimethoprim-sulfamethoxazole | Unknown | 72 mg | — |
| Subject | trimethoprim-sulfamethoxazole | Unknown | 80 mg | — |
| Subject | trimethoprim-sulfamethoxazole | Unknown | 160 mg | — |
| Background | CEPHALEXIN ANHYDROUS | Small molecule | 300 mg | — |
| Background | CEPHALEXIN ANHYDROUS | Small molecule | 400 mg | — |
| Background | CEPHALEXIN ANHYDROUS | Small molecule | 500 mg | — |
| Background | CEPHALEXIN ANHYDROUS | Small molecule | 1000 mg | — |